‘Brain in a dish’ gives scientists ‘unprecedented’ ability to study neurodevelopment disorders

Screen Shot at PM

Small cultures of human neuronal cells developing in a dish are not quite “brains in a petri dish” as they are sometimes described. But these cerebral organoids give scientists unprecedented options for studying and understanding the early embryonic stages of human brain development. Two recent papers published in Nature show just how powerful these neuroscience research tools are. The first paper characterizes these neural developments more fully, while the second uses organoids as a tool to show how a neurodevelopmental disorder known as Timothy Syndrome develops.

The first paper focused on fully understanding brain organoids, which start out as a cluster of neural stem cells.

Overall, the paper showed that the cells in mature brain organoids have the same structural traits as mature neurons, including dense dendritic spines.

In the second paper on brain organoids, the authors describe how they treated their cultured brain cells with growth factors that stimulated the development of organoids that resembled the forebrain.

This type of study, the authors suggest, could also allow for the examination of various other neurological diseases that couldn’t previously be modeled in a cell culture dish.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: “Brains in a dish” move out of science fiction and into the lab

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
Screenshot-2026-05-08-at-3.40.33-PM
Seeds of power: China turns to genetic engineering to become global superpower
ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDA’s expedited drug reviews are hailed in some quarters but other approval practices are problematic
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?
Farmers can talk to plants
Farmers are a major source of misinformation—about farming
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
circular-bioeconomy-should-focus-on-sustainable-wellbeing
GLP podcast: What's wrong with 'doomsday' environmentalism? It's false.
Screenshot 2026-05-08 at 3.01
Transforming farming and nutrition with AI and robotics? Larry Ellison’s half-billion-dollar Hawaii greenhouse dream goes bust
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.